1h Free Analyst Time
The publisher has been monitoring the genetic testing market in APAC and it is poised to grow by $1.31 bn during 2022-2026, progressing at a CAGR of 13.21% during the forecast period. The report on the genetic testing market in APAC provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising approval of advanced genetic testing products and increasing application of genetic testing in oncology.
The genetic testing market in APAC analysis includes product and application segments.
The genetic testing market in APAC is segmented as below:
By Product
- Equipment
- Consumables
By Application
- Cancer diagnosis
- Genetic disease diagnosis
- Cardiovascular disease diagnosis
- Others
This study identifies the rising strategic partnership as one of the prime reasons driving the genetic testing market growth in APAC during the next few years.
The report on genetic testing market in APAC covers the following areas:
- Genetic testing market sizing
- Genetic testing market forecast
- Genetic testing market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genetic testing market vendors in APAC that include Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., Exact Sciences Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., Mapmygenome India Ltd., Myriad Genetics Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. Also, the genetic testing market in APAC analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021 - 2026
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Equipment - Market size and forecast 2021-2026
- Consumables - Market size and forecast 2021-2026
- Market opportunity by Product
Market Segmentation by Application
- Market segments
- Comparison by Application
- Cancer diagnosis - Market size and forecast 2021-2026
- Genetic disease diagnosis - Market size and forecast 2021-2026
- Cardiovascular disease diagnosis - Market size and forecast 2021-2026
- Others - Market size and forecast 2021-2026
- Market opportunity by Application
Customer landscape
- Overview
Drivers, Challenges, and Trends
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Vendor Disruption
- Competitive Scenario
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- Bio Rad Laboratories Inc.
- Danaher Corp.
- Exact Sciences Corp.
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- Mapmygenome India Ltd.
- Myriad Genetics Inc.
- QIAGEN NV
- Thermo Fisher Scientific Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research Methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2021 - 2026 ($ million)
- Global market: Year-over-year growth 2021 - 2026 (%)
- Five forces analysis 2021 & 2026
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2021
- Product - Market share 2021-2026 (%)
- Comparison by Product
- Equipment - Market size and forecast 2021-2026 ($ million)
- Equipment - Year-over-year growth 2021-2026 (%)
- Consumables - Market size and forecast 2021-2026 ($ million)
- Consumables - Year-over-year growth 2021-2026 (%)
- Market opportunity by Product
- Application - Market share 2021-2026 (%)
- Comparison by Application
- Cancer diagnosis - Market size and forecast 2021-2026 ($ million)
- Cancer diagnosis - Year-over-year growth 2021-2026 (%)
- Genetic disease diagnosis - Market size and forecast 2021-2026 ($ million)
- Genetic disease diagnosis - Year-over-year growth 2021-2026 (%)
- Cardiovascular disease diagnosis - Market size and forecast 2021-2026 ($ million)
- Cardiovascular disease diagnosis - Year-over-year growth 2021-2026 (%)
- Others - Market size and forecast 2021-2026 ($ million)
- Others - Year-over-year growth 2021-2026 (%)
- Market opportunity by Application
- Customer landscape
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Key customers
- Abbott Laboratories - Segment focus
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Key customers
- Bio Rad Laboratories Inc. - Segment focus
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key offerings
- Danaher Corp. - Key customers
- Danaher Corp. - Segment focus
- Exact Sciences Corp. - Overview
- Exact Sciences Corp. - Business segments
- Exact Sciences Corp. - Key offerings
- Exact Sciences Corp. - Key customers
- Exact Sciences Corp. - Segment focus
- F. Hoffmann-La Roche Ltd. - Overview
- F. Hoffmann-La Roche Ltd. - Business segments
- F. Hoffmann-La Roche Ltd. - Key offerings
- F. Hoffmann-La Roche Ltd. - Key customers
- F. Hoffmann-La Roche Ltd. - Segment focus
- Illumina Inc. - Overview
- Illumina Inc. - Product and service
- Illumina Inc. - Key offerings
- Illumina Inc. - Key customers
- Illumina Inc. - Segment focus
- Mapmygenome India Ltd. - Overview
- Mapmygenome India Ltd. - Product and service
- Mapmygenome India Ltd. - Key offerings
- Mapmygenome India Ltd. - Key customers
- Mapmygenome India Ltd. - Segment focus
- Myriad Genetics Inc. - Overview
- Myriad Genetics Inc. - Business segments
- Myriad Genetics Inc. - Key offerings
- Myriad Genetics Inc. - Key customers
- Myriad Genetics Inc. - Segment focus
- QIAGEN NV - Overview
- QIAGEN NV - Business segments
- QIAGEN NV - Key offerings
- QIAGEN NV - Key customers
- QIAGEN NV - Segment focus
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Key customers
- Thermo Fisher Scientific Inc. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the genetic testing market in APAC: Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., Exact Sciences Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., Mapmygenome India Ltd., Myriad Genetics Inc., QIAGEN NV, and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising strategic partnership.'
According to the report, one of the major drivers for this market is the rising approval of advanced genetic testing products.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Bio Rad Laboratories Inc.
- Danaher Corp.
- Exact Sciences Corp.
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- Mapmygenome India Ltd.
- Myriad Genetics Inc.
- QIAGEN NV
- Thermo Fisher Scientific Inc.
